
Cecile H. Vo
Examiner (ID: 6019, Phone: (571)270-3031 , Office: P/2153 )
| Most Active Art Unit | 2153 |
| Art Unit(s) | 2153, 2169 |
| Total Applications | 495 |
| Issued Applications | 315 |
| Pending Applications | 30 |
| Abandoned Applications | 158 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7045206
[patent_doc_number] => 20050249801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Stabilization of solid drug formulations'
[patent_app_type] => utility
[patent_app_number] => 11/184341
[patent_app_country] => US
[patent_app_date] => 2005-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5984
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20050249801.pdf
[firstpage_image] =>[orig_patent_app_number] => 11184341
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/184341 | Stabilization of solid drug formulations | Jul 18, 2005 | Abandoned |
Array
(
[id] => 5799150
[patent_doc_number] => 20060034776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics'
[patent_app_type] => utility
[patent_app_number] => 11/182382
[patent_app_country] => US
[patent_app_date] => 2005-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14459
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034776.pdf
[firstpage_image] =>[orig_patent_app_number] => 11182382
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/182382 | Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics | Jul 14, 2005 | Abandoned |
Array
(
[id] => 5799149
[patent_doc_number] => 20060034775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Aerosol formulation for inhalation containing an anticholinergic'
[patent_app_type] => utility
[patent_app_number] => 11/181517
[patent_app_country] => US
[patent_app_date] => 2005-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4023
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034775.pdf
[firstpage_image] =>[orig_patent_app_number] => 11181517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/181517 | Aerosol formulation for inhalation containing an anticholinergic | Jul 13, 2005 | Abandoned |
Array
(
[id] => 5766596
[patent_doc_number] => 20060018840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Aerosolizable formulation comprising nicotine'
[patent_app_type] => utility
[patent_app_number] => 11/169153
[patent_app_country] => US
[patent_app_date] => 2005-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10850
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018840.pdf
[firstpage_image] =>[orig_patent_app_number] => 11169153
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/169153 | Aerosolizable formulation comprising nicotine | Jun 27, 2005 | Abandoned |
Array
(
[id] => 6977362
[patent_doc_number] => 20050287078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Minimizing powder retention on surfaces'
[patent_app_type] => utility
[patent_app_number] => 11/154692
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10254
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287078.pdf
[firstpage_image] =>[orig_patent_app_number] => 11154692
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/154692 | Minimizing powder retention on surfaces | Jun 16, 2005 | Abandoned |
Array
(
[id] => 4442582
[patent_doc_number] => 07928144
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-19
[patent_title] => 'Antiinflammatory and analgesic preparation for external use'
[patent_app_type] => utility
[patent_app_number] => 11/629367
[patent_app_country] => US
[patent_app_date] => 2005-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6118
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/928/07928144.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629367
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629367 | Antiinflammatory and analgesic preparation for external use | Jun 14, 2005 | Issued |
Array
(
[id] => 4791589
[patent_doc_number] => 20080292562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Medicaments For Inhalation Comprising Pde IV Inhibitors and Enantiomerically Pure Glycopyrrolate Salts'
[patent_app_type] => utility
[patent_app_number] => 11/572199
[patent_app_country] => US
[patent_app_date] => 2005-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9260
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20080292562.pdf
[firstpage_image] =>[orig_patent_app_number] => 11572199
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/572199 | Medicaments For Inhalation Comprising Pde IV Inhibitors and Enantiomerically Pure Glycopyrrolate Salts | Jun 12, 2005 | Abandoned |
Array
(
[id] => 5210914
[patent_doc_number] => 20070249498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Method of Applying Pesticides'
[patent_app_type] => utility
[patent_app_number] => 11/569754
[patent_app_country] => US
[patent_app_date] => 2005-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5362
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20070249498.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569754
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569754 | Method of applying pesticides | Jun 8, 2005 | Issued |
Array
(
[id] => 6951807
[patent_doc_number] => 20050226901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Dermatological composition'
[patent_app_type] => utility
[patent_app_number] => 11/142332
[patent_app_country] => US
[patent_app_date] => 2005-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9819
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20050226901.pdf
[firstpage_image] =>[orig_patent_app_number] => 11142332
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/142332 | Method of protecting skin from UV radiation using a dermatological composition having porous silicon | Jun 1, 2005 | Issued |
Array
(
[id] => 5013479
[patent_doc_number] => 20070256687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Enhanced Medical Product'
[patent_app_type] => utility
[patent_app_number] => 11/629803
[patent_app_country] => US
[patent_app_date] => 2005-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7074
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20070256687.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629803
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629803 | Enhanced Medical Product | May 31, 2005 | Abandoned |
Array
(
[id] => 4669428
[patent_doc_number] => 20080044488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Nano Glass Powder and Use Thereof, in Particular Multicomponent Glass Powder with a Mean Particle Size of Less Than 1 µm'
[patent_app_type] => utility
[patent_app_number] => 11/597959
[patent_app_country] => US
[patent_app_date] => 2005-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4990
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044488.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597959
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597959 | Nano glass powder and use thereof, in particular multicomponent glass powder with a mean particle size of less than 1 μm | May 24, 2005 | Issued |
Array
(
[id] => 5622101
[patent_doc_number] => 20060260606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Inhalable formulations of amphotericin B and methods and devices for delivery thereof'
[patent_app_type] => utility
[patent_app_number] => 11/131964
[patent_app_country] => US
[patent_app_date] => 2005-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3691
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20060260606.pdf
[firstpage_image] =>[orig_patent_app_number] => 11131964
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/131964 | Inhalable formulations of amphotericin B and methods and devices for delivery thereof | May 17, 2005 | Abandoned |
Array
(
[id] => 4859036
[patent_doc_number] => 20080267886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists'
[patent_app_type] => utility
[patent_app_number] => 11/568559
[patent_app_country] => US
[patent_app_date] => 2005-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9943
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20080267886.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568559
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568559 | Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists | May 16, 2005 | Abandoned |
Array
(
[id] => 7225041
[patent_doc_number] => 20050255050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Powder formulations for inhalation, comprising enantiomerically pure beta agonists'
[patent_app_type] => utility
[patent_app_number] => 11/128141
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10799
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255050.pdf
[firstpage_image] =>[orig_patent_app_number] => 11128141
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/128141 | Powder formulations for inhalation, comprising enantiomerically pure beta agonists | May 11, 2005 | Abandoned |
Array
(
[id] => 5904481
[patent_doc_number] => 20060046962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Absorption enhancers for drug administration'
[patent_app_type] => utility
[patent_app_number] => 11/127786
[patent_app_country] => US
[patent_app_date] => 2005-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16480
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20060046962.pdf
[firstpage_image] =>[orig_patent_app_number] => 11127786
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/127786 | Absorption enhancers for drug administration | May 10, 2005 | Abandoned |
Array
(
[id] => 4909282
[patent_doc_number] => 20080020048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Treatment of Respiratory Disease'
[patent_app_type] => utility
[patent_app_number] => 11/587718
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3509
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20080020048.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587718
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587718 | Treatment of Respiratory Disease | May 9, 2005 | Abandoned |
Array
(
[id] => 7233622
[patent_doc_number] => 20050256115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Aerosol formulation for the inhalation of beta-agonists'
[patent_app_type] => utility
[patent_app_number] => 11/125756
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15837
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256115.pdf
[firstpage_image] =>[orig_patent_app_number] => 11125756
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/125756 | Aerosol formulation for the inhalation of beta-agonists | May 9, 2005 | Abandoned |
Array
(
[id] => 7045081
[patent_doc_number] => 20050249676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Pullulan capsules'
[patent_app_type] => utility
[patent_app_number] => 11/121226
[patent_app_country] => US
[patent_app_date] => 2005-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6552
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20050249676.pdf
[firstpage_image] =>[orig_patent_app_number] => 11121226
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/121226 | Pullulan capsules | May 2, 2005 | Abandoned |
Array
(
[id] => 5766936
[patent_doc_number] => 20060018940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Stabilized antimicrobial composition'
[patent_app_type] => utility
[patent_app_number] => 11/117625
[patent_app_country] => US
[patent_app_date] => 2005-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8981
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018940.pdf
[firstpage_image] =>[orig_patent_app_number] => 11117625
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/117625 | Stabilized antimicrobial composition | Apr 27, 2005 | Abandoned |
Array
(
[id] => 8363272
[patent_doc_number] => 08252334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-28
[patent_title] => 'Dry powder pharmaceutical compositions comprising surfactants, hydrophobic active principles, and water-soluble excipients, process of preparing, and stable aqueous suspensions thereof'
[patent_app_type] => utility
[patent_app_number] => 11/578661
[patent_app_country] => US
[patent_app_date] => 2005-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 8933
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11578661
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578661 | Dry powder pharmaceutical compositions comprising surfactants, hydrophobic active principles, and water-soluble excipients, process of preparing, and stable aqueous suspensions thereof | Apr 20, 2005 | Issued |